VWM
PFE icon

Vermillion Wealth Management’s Pfizer PFE Stock Holding History

Vermillion Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.9K Sell
1,989
-363
-15% -$9.5K 0.01% 642
2026
Q1 		$66K Buy
2,352
+382
+19% +$10.2K 0.03% 176
2025
Q4 		$49K Buy
1,970
+10
+0.5% +$252 0.02% 201
2025
Q3 		$50K Sell
1,960
-91
-4% -$2.25K 0.01% 586
2025
Q2 		$49.7K Buy
2,051
+10
+0.5% +$233 0.02% 181
2025
Q1 		$51.7K Sell
2,041
-359
-15% -$9.39K 0.02% 505
2024
Q4 		$63.7K Buy
+2,400
New +$65.1K 0.03% 161

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vermillion Wealth Management's PFE Position: Q2 2026 in Review

Vermillion Wealth Management reduced its Pfizer (PFE) stake by 15% in Q2 2026, selling an estimated $9.5K and leaving 1,989 shares worth $47.9K. The position accounts for 0.01% of the portfolio, ranked #642.

Vermillion Wealth Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $66K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Vermillion Wealth Management held 1,989 shares of Pfizer worth $47.9K as of Q2 2026.
  • Vermillion Wealth Management sold 363 Pfizer shares in Q2 2026, an estimated $9.5K.
  • Pfizer made up 0.01% of Vermillion Wealth Management's portfolio in Q2 2026, its #642 holding.
  • Vermillion Wealth Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Vermillion Wealth Management's Pfizer position peaked at $66K in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.